Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2021 October;112(5) > Minerva Medica 2021 October;112(5):661-3

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

LETTERS TO THE EDITOR   

Minerva Medica 2021 October;112(5):661-3

DOI: 10.23736/S0026-4806.20.06479-4

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

miR-26a inhibits the proliferation and migration of prostate cancer by targeting CDC6

Hui LI 1 ✉, Weiran XU 2, Tian WANG 1, Chengfan YU 1, Xiaosong RAO 3, Xin HONG 1, Xiaofeng WANG 1

1 Department of Urologic Surgery, Peking University International Hospital, Beijing, China; 2 Department of Internal Medicine-Oncology, Peking University International Hospital, Beijing, China; 3 Department of Pathology, Peking University International Hospital, Beijing, China


HTML PDF


top of page

 

Copyright © 2024 Edizioni Minerva Medica

Corporate information        Privacy policy        Terms and conditions